Description
Composition and action of BRILINTA 90 MG AstraZeneca, profile of the main ingredient
BRILINTA 90 MG, produced by AstraZeneca, is primarily composed of Ticagrelor, an antiplatelet medication that functions by inhibiting platelet aggregation. It is designed to reduce the risk of cardiovascular events in patients with acute coronary syndrome or those who have experienced a heart attack. The mechanism of action relies on Ticagrelor’s ability to block the P2Y12 receptor on platelets, leading to a reduced formation of blood clots.
In addition to its primary component, BRILINTA contains several inactive ingredients that aid in the absorption and effectiveness of the medication. These help in delivering Ticagrelor efficiently in the body, ensuring optimal performance. This attribute makes BRILINTA particularly vital for athletes and fitness enthusiasts who require enhanced recovery and decreased risks of vascular events during rigorous training sessions.
- Active Ingredient: Ticagrelor
- Form: Oral tablet
- Dosing: 90 MG per tablet
- Indication: Acute coronary syndrome prevention
- Manufacturer: AstraZeneca
Effectiveness in training, muscle adaptation and energy
Although BRILINTA is not traditionally categorized as a performance-enhancing drug, its role in promoting better blood circulation can potentially assist athletes during intense training. Efficient blood flow is crucial in delivering oxygen and nutrients to muscle tissues. This improvement in circulation can assist in muscle adaptation, enabling athletes to experience better endurance and quicker recovery.
Moreover, the reduction of blood clot formation might lead to less fatigue during prolonged exercise. As the body adapts to training, athletes may find themselves able to push harder without the increased risk of overexertion that could result in serious cardiovascular issues. This alignment with rigorous physical demands makes BRILINTA a focus point for discussions related to sports pharmacology, especially in terms of cardiovascular health during intense training.
How to get BRILINTA 90 MG AstraZeneca online, advantages of our store
Acquiring BRILINTA 90 MG online is increasingly convenient, especially through reputable pharmacies. Before ordering, it is essential to consult with a healthcare professional to ensure that the medication aligns with your health needs, particularly if you are an athlete. Many online stores provide easy access to BRILINTA with discreet shipping options.
Our store stands out for several reasons:
- Competitive pricing and discounts available
- Fast and reliable shipping services
- Accessibility for international orders
- Customer support for queries regarding your order
- Secure payment options ensuring privacy and safety
We prioritize customer satisfaction and health compliance, making your online shopping experience seamless.
Optimal cycle duration, when to start and stop
The optimal cycle duration for taking BRILINTA can vary depending on individual health conditions and athletic goals. Generally, it is advisable to consult with a healthcare provider to determine the precise timeline. Starting with an introductory period might help determine how your body reacts to the medication.
Typically, athletes might consider a cycle ranging from 3 to 6 months, depending on training intensity and overall cardiovascular health. It is important to monitor your body’s response closely. Stopping the medication should also be done under a healthcare provider’s guidance to prevent any adverse effects.
Possible adverse effects, important precautions
As with any medication, BRILINTA may present some adverse effects. While not every user will experience these, understanding potential risks is crucial for safety. Common adverse effects can include:
- Bleeding or bruising more easily
- Shortness of breath
- Dizziness or lightheadedness
- Nausea or vomiting
Utilizing BRILINTA requires important precautions. Individuals with a history of bleeding disorders, active bleeding, or severe liver issues should approach this medication with caution and under strict medical supervision. These factors underline the importance of comprehensive health evaluations before beginning a BRILINTA regimen, especially in a sports environment.
Additional information
| Active substance | Ticagrelor |
|---|---|
| Water Retention | None |
| Hepatotoxicity | Low risk |
| Lab Test | Not specific, may monitor platelet function tests |
| Also known as | AZD6140 |
| Blood pressure | Can cause transient increase |
| Trade name | Brilinta, Brilique, Possia |
| FORM | 56 pills x 90 mg |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | (1S,2S,3R,5R)-3-[7-[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino]-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Formula | C23H28F2N6O4S |
| Substance class | Antiplatelet agent |
| Main action | Platelet aggregation inhibitor |
| Half-life | Approximately 7 to 8.5 hours |
| Dosage (medical) | Typically 90 mg twice daily |
| Dosage (sports) | Not applicable |
| Effects | Reduces the rate of stent thrombosis in patients who are at risk, decreases myocardial infarction |
| Side effects | Bleeding, dyspnea, headache, cough, hypertension, nausea |
| Use in sports | Not typically used in sports |
| Manufacturer | AstraZeneca |
Related products
-

Norvacs 5 mg Pfizer
0 out of 5€24.00 Add to basket -

Fostimon (Merional) 75 (HMG) IBSA
0 out of 5€43.00 Add to basket -

Clexane 0.4 Sanofi
0 out of 5€44.00 Add to basket -

Dihydroboldos 100 mg Driada Medical
0 out of 5€0.00 Select options This product has multiple variants. The options may be chosen on the product page

Reviews
There are no reviews yet.